Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06765265
PHASE4
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
Sponsor: King Edward Medical University
View on ClinicalTrials.gov
Summary
there will be 2 groups of patients with acute coronary syndrome. The patients will receive one of the 2 study drugs and impact on raising Vitamin D level will be seen after 6 months
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
152
Start Date
2025-01-05
Completion Date
2026-01-01
Last Updated
2025-03-11
Healthy Volunteers
No
Conditions
Interventions
DRUG
Rosuvastatin 20 mg/day
Rosuvastatin 20 mg / Day for 24 weeks
DRUG
Atorvastatin 40 mg
Atorvastatin 40mg / Day for 24 weeks
Locations (1)
King Edward Medical University
Lahore, Punjab Province, Pakistan